1397682-63-1

Usage

Uses

Used in Bioconjugation:
Propargyl-PEG5-beta-D-galactose is used as a crosslinker for bioconjugation, allowing the selective and efficient attachment of azide-bearing biomolecules, such as proteins, peptides, or nucleic acids, through stable triazole linkages. This enhances the stability, solubility, and bioavailability of the conjugated biomolecules, making it suitable for applications in drug delivery, diagnostics, and therapeutics.
Used in Drug Delivery Systems:
In the pharmaceutical industry, Propargyl-PEG5-beta-D-galactose is used as a component in the development of drug delivery systems. Its ability to form stable triazole linkages with azide-modified drugs allows for the creation of targeted and controlled-release drug conjugates. This can improve the efficacy and reduce the side effects of various therapeutic agents.
Used in Diagnostics:
Propargyl-PEG5-beta-D-galactose is used as a labeling agent in diagnostic applications, such as immunoassays and molecular imaging. The propargyl group can be used to attach detection moieties, like fluorescent dyes or radioactive isotopes, to biomolecules, enabling their detection and quantification in biological samples.
Used in Material Science:
In the field of material science, Propargyl-PEG5-beta-D-galactose can be employed as a component in the development of biocompatible and biodegradable materials. Its ability to form stable linkages with other molecules can be utilized to create hydrogels, scaffolds, or other structures with tailored properties for tissue engineering or regenerative medicine applications.

Upstream product

• 1360446-31-6 C₂₅H₃₈O₁₄ 
• 83-87-4 D-glucose pentaacetate 
• 1397682-61-9 3,6,9,12-tetraoxapentadec-14-ynyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside 
• 112-60-7 Tetraethylene glycol 
• 87450-10-0 3,6,9,12-tetraoxapentadec-14-yn-1-ol 
• 4163-60-4 β-D-galactose peracetate 

Relevant academic research and scientific papers

NIR fluorescent DCPO glucose analogues and their application in cancer cell imaging

Given the increased glucose uptake in cancer cells than normal cells, near-infrared (NIR) fluorescent glucose analogues have been previously synthesized and applied in cancer cell imaging. However, most NIR dyes usually have one or more charge in their structures, which may cause low cell membrane permeability and hamper their application in cell imaging. Here we report the synthesis and characterization of a series of DCPO-conjugated glucose analogues (N0-N4), which have no charge in their structures and have different lengths of the spacer arm. Experiments in different cancer cell lines showed the uptake of N0-N4 was dependent on the protein levels of GLUT-1. The distance between the dyes and glucose was adjusted by the length of PEG. Of these five glucose analogues, the length of the linker in N2 which contains a diethylene glycol was the most appropriate spacer arm, a longer or shorter linker exhibited reduced cellular uptake efficiency. Moreover, the uptake of DCPO-conjugated glucose analogues could be inhibited by phloretin, a GLUT-1 inhibitor or competitively inhibited by unlabeled d-glucose. Therefore, our study has reported a novel type of NIR-conjugated glucose analogues, whose cell permeability ensured the potential application for cancer cell bioimaging in the NIR region. We also demonstrated, for the first time, that the length of the linker between the dyes and glucose was also an important factor that will affect the delivery efficiency of the glucose analogues to cells.

Mimicking biological membranes with programmable glycan ligands self-assembled from amphiphilic Janus glycodendrimers

An accelerated modular synthesis produced 18 amphiphilic Janus glycodendrimers with three different topologies formed from either two or one carbohydrate head groups or a mixed constellation with a noncarbohydrate hydrophilic arm. By simple injection of their THF solutions into water or buffer, all of the Janus compounds self-assembled into uniform, stable, and soft unilamellar vesicles, denoted glycodendrimersomes. The mixed constellation topology glycodendrimersomes were demonstrated to be most efficient in binding plant, bacterial, and human lectins. This evidence with biomedically relevant receptors offers a promising perspective for the application of such glycodendrimersomes in targeted drug delivery, vaccines, and other areas of nanomedicine.